Adamas Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Adamas Pharmaceuticals's estimated annual revenue is currently $35M per year.
- Adamas Pharmaceuticals's estimated revenue per employee is $660,377
- Adamas Pharmaceuticals's total funding is $141.2M.
Employee Data
- Adamas Pharmaceuticals has 53 Employees.
- Adamas Pharmaceuticals grew their employee count by -12% last year.
Adamas Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP Strategy & Planning | Reveal Email/Phone |
2 | VP Marketing | Reveal Email/Phone |
3 | Head Corporate Communications, Patient Advocacy and Engagement | Reveal Email/Phone |
4 | Head Corporate Development, Strategy, Portfolio Planning and Alliance Management | Reveal Email/Phone |
5 | Head Human Resources | Reveal Email/Phone |
6 | VP Information Technology | Reveal Email/Phone |
7 | Director, Commercial Training | Reveal Email/Phone |
8 | Associate Director Information and Security and Governance | Reveal Email/Phone |
9 | Senior Director, IT, Infrastructure, Operations and Security | Reveal Email/Phone |
10 | Chief Financial Officer | Reveal Email/Phone |
Adamas Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Adamas Pharmaceuticals?
Adamas is an emerging pharmaceutical company focused on developing small molecule, Advantaged Therapeutics™ to treat neurological and infectious diseases, including influenza A, the cause of the current flu pandemic. Adamas’ approach to pharmaceutical development is to identify and match proven drug mechanisms that can be developed as optimized combination drug therapies to increase safety, efficacy and compliance, thus improving upon the standard of care. Adamas is headquartered in Emeryville, California, with operations in Bangalore, India.
keywords:N/A
$141.2M
Total Funding
53
Number of Employees
$35M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Adamas Pharmaceuticals News
Prior to Adamas, Mathieson served as chief executive officer for Research Autism, a non-profit organization focused on autism research and...
... Md., April 13, 2022 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, ... costs associated with the acquisition of Adamas Pharmaceuticals,...
ROCKVILLE, Md., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Supernus’ proposed acquisition of Adamas Pharmaceuticals, Inc. ...
Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio October 11, 2021 n Acquisition of two marketed products diversifies and accelerates revenue and cash flow n Expected to be significantly accretive in 2022 n Potential synergies of $60 millio ...
First quarter 2021 total revenues of $19.3 million, a 33% increase over first quarter 2020 GOCOVRI New paid prescriptions of 590, an 18% increase over first quarter 2020 EMERYVILLE, Calif., May 10, 2021 --Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delive ...
Other Companies in Oakland
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15.4M | 53 | -4% | N/A |
#2 | $3.5M | 53 | 0% | N/A |
#3 | $8.6M | 53 | 4% | N/A |
#4 | $6.7M | 53 | 6% | N/A |
#5 | $10.7M | 53 | 0% | N/A |